Physician Wealth Advisors’s Rentokil RTO Stock Holding History

Physician Wealth Advisors’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-13	Closed	-$372	–	2578
2026 Q2	$372	Sell	13 -28	-68%	-$889	﹤0.01%	2265
2026 Q1	$1.29K	Hold	41	–	–	﹤0.01%	1543
2025 Q4	$1.21K	Buy	41 +13	+46%	+$361	﹤0.01%	1516
2025 Q3	$707	Hold	28	–	–	﹤0.01%	1729
2025 Q2	$672	Buy	+28	New	+$649	﹤0.01%	1625
2025 Q1	–	Sell	-24	Closed	-$608	–	1517
2024 Q4	$608	Buy	+24	New	+$608	﹤0.01%	1087

Other funds holding RTO

Nichols & Pratt Advisers Boston, Massachusetts $1.68B AUM 20.22% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Pacifica Capital Investments Leander, Texas $282M AUM 5.46% 1-Year Est. Return

Iridian Asset Management Westport, Connecticut $275M AUM 37.66% 1-Year Est. Return

ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return

IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Park Avenue Securities New York $16.4B AUM 18.52% 1-Year Est. Return

Physician Wealth Advisors's RTO Position: Q3 2026 in Review

Physician Wealth Advisors sold out of Rentokil (RTO) in Q3 2026, closing a stake of 13 shares — an estimated $372 sold.

Physician Wealth Advisors first reported a position in RTO in Q4 2024 and held it in 6 quarters. The position peaked at $1.29K in Q1 2026. 107 funds tracked by Wall St. Rank hold RTO as of Q3 2026.

Physician Wealth Advisors reported no remaining Rentokil position as of Q3 2026 after selling out during the quarter.
Physician Wealth Advisors sold 13 Rentokil shares in Q3 2026, an estimated $372.
Physician Wealth Advisors first reported a position in Rentokil in Q4 2024 and held it in 6 quarters.
Physician Wealth Advisors's Rentokil position peaked at $1.29K in Q1 2026.
107 funds tracked by Wall St. Rank held Rentokil as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.